'Rosuvastatin' presentation slideshows

CRESTOR TM (rosuvastatin) Clinical Overview

CRESTOR TM (rosuvastatin) Clinical Overview. CRESTOR and GALAXY Programme are trade marks of the AstraZeneca group of companies Licensed from Shionogi & Co. Ltd, Osaka, Japan. Contents. Disease Area Background Rosuvastatin Clinical Development Programme Efficacy Safety and Tolerability

4.2k views • 58 slides

STELLAR - Study Design

STELLAR - Study Design. 6 week, randomised, open-label, parallel-group, fixed-dose treatment 2268 adults with primary hypercholesterolaemia Randomised to 14 groups rosuvastatin 10, 20, 40 mg atorvastatin 10, 20, 40 or 80 mg simvastatin 10, 20, 40 or 80 mg

2.38k views • 44 slides

CASE 3

341 views • 6 slides

Adverse events for rosuvastatin

Adverse events for rosuvastatin. Bennett WM, moderator. Forum. Postgraduate Education Course. Renal Week 2005; November 8-13, 2005; Philadelphia, PA. Renal clearance of statins. Bennett WM, moderator. Forum. Postgraduate Education Course. Renal Week 2005; November 8-13, 2005; Philadelphia, PA.

256 views • 2 slides